Work

Head‐to‐head comparison of the pharmacokinetic profiles of a high‐purity factor IX concentrate (AlphaNine®) and a recombinant factor IX (BeneFIX®) in patients with severe haemophilia B

Year: 2013

Type: article

Source: Haemophilia

DOI: 10.1111/hae.12148

Authors: T. Lissitchkov, M. Matysiak, K. Zavilska, P. Laguna, L. Gercheva, A. Antonov, A. Moret, P. Caunedo, J. A. Aznar, M. K. Woodward, A. Páez

Institutions: Medical University of Warsaw, Poznan University of Medical Sciences, University Hospital St. Marina, Medical University Pleven, Hospital Universitari i Politècnic La Fe, Grifols (Spain)

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2005221472

FWCI: 4.046

Cites: 19

Cited by: 28

Related to: 10